Immunocore Holdings plc Quarterly Return On Equity in % from Q4 2023 to Q1 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Immunocore Holdings plc quarterly/annual Return On Equity history and growth rate from Q4 2023 to Q1 2025.
  • Immunocore Holdings plc Return On Equity for the quarter ending March 31, 2025 was -5.86 %, a 65.1% increase year-over-year.
  • Immunocore Holdings plc annual Return On Equity for 2024 was -14 %, a 10.1% increase from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2025 -5.86 +10.9 +65.1% Jan 1, 2025 Mar 31, 2025
Q4 2024 -14 +1.58 +10.1% Oct 1, 2024 Dec 31, 2024
Q3 2024 -12.8 Jul 1, 2024 Sep 30, 2024
Q2 2024 -15.2 Apr 1, 2024 Jun 30, 2024
Q1 2024 -16.8 Jan 1, 2024 Mar 31, 2024
Q4 2023 -15.6 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.